<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2025.1644593</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Study on the application of modified negative pressure wound therapy with instillation in cervical anastomotic leakage after oesophageal cancer surgery</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Zhou</surname><given-names>Linrong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Li</surname><given-names>Cui</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Guan</surname><given-names>Xuehong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Xie</surname><given-names>Jing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Lin</surname><given-names>Wanli</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Wu</surname><given-names>Bomeng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname><given-names>Ying</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Huang</surname><given-names>Jiawei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3002801/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Gong</surname><given-names>Lanjuan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Thoracic Surgery, Gaozhou People&#x2019;s Hospital</institution>, <city>Maoming</city>, <state>Guangdong</state>,&#xa0;<country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>Guangdong Oesophageal Cancer Institute Gaozhou Branch</institution>, <city>Gaozhou</city>,&#xa0;<country country="cn">China</country></aff>
<aff id="aff3"><label>3</label><institution>Nursing Department, Gaozhou People&#x2019;s Hospital</institution>, <city>Maoming</city>, <state>Guangdong</state>,&#xa0;<country country="cn">China</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Jiawei Huang, <email xlink:href="mailto:hjw15992198147@163.com">hjw15992198147@163.com</email>; Lanjuan Gong, <email xlink:href="mailto:gonglanjuan8161@163.com">gonglanjuan8161@163.com</email></corresp>
<fn fn-type="equal" id="fn003">
<label>&#x2020;</label>
<p>These authors have contributed equally to this work and share first authorship</p></fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-12-01">
<day>01</day>
<month>12</month>
<year>2025</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1644593</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>06</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>04</day>
<month>11</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Zhou, Li, Guan, Xie, Lin, Wu, Chen, Huang and Gong.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Zhou, Li, Guan, Xie, Lin, Wu, Chen, Huang and Gong</copyright-holder>
<license>
<ali:license_ref start_date="2025-12-01">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Aims</title>
<p>This study aims to explore the feasibility and safety of modified negative-pressure wound therapy with instillation (NPWTi) for the treatment of cervical anastomotic leakage (CAL) after oesophageal cancer surgery.</p>
</sec>
<sec>
<title>Methods</title>
<p>A retrospective analysis was conducted on 17 patients who developed CAL after oesophageal cancer surgery and received modified NPWTi treatment at our hospital from 2021 to 2024. The primary outcome was the time to healing, defined as the number of days from the initiation of modified NPWTi to complete fistula closure. Secondary outcomes included wound odour improvement and patient comfort.</p>
</sec>
<sec>
<title>Results</title>
<p>A total of 17 patient were collected, including 10 men and seven women, with an average age of 73.71 &#xb1; 8.01 years. None received neoadjuvant therapy, and no patients had diabetes; preoperative albumin was 38.77 &#xb1; 3.58 g/L. The occurrence of CAL was noted at 8.88 &#xb1; 3.15&#xa0;d (95% CI: 7.26 to 10.51&#xa0;d) post-surgery. The modified treatment was commenced 0&#x2013;12 d after CAL diagnosis, with the earliest case starting on the day of diagnosis. The mean duration of modified NPWTi was 10.88 &#xb1; 6.54&#xa0;d (95% CI: 7.52 to 14.25&#xa0;d). For the primary outcome, the time from treatment initiation to complete healing was 15.00 &#xb1; 7.26&#xa0;d (95% CI: 11.27 to 18.73&#xa0;d), with a minimum of five days. No mediastinal or pleural infections related to NPWTi occurred during the treatment. For the secondary outcomes, a significant improvement in wound odour was observed following the administration of the modified NPWTi (P&lt;0.001), with an improvement rate of 100% (95% CI: 85-100%). During the treatment, the patients reported feeling comfortable and expressed overall satisfaction.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Modified NPWTi demonstrated significant efficacy and convenience in treating CAL after oesophageal cancer surgery, benefiting both patients and healthcare providers with good safety profiles, thus warranting broader clinical application.</p>
</sec>
</abstract>
<kwd-group>
<kwd>negative-pressure wound therapy with instillation</kwd>
<kwd>oesophageal cancer</kwd>
<kwd>cervical anastomotic leakage</kwd>
<kwd>odour management</kwd>
<kwd>negative-pressure wound therapy</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by the Guangdong Medical Research Fund Project in 2023 (B2023212) and the Guangdong Provincial Oesophageal Cancer Research Institute Science and Technology Plan Project (M202410).</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="18"/>
<page-count count="7"/>
<word-count count="2708"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Gastrointestinal Cancers: Gastric and Esophageal Cancers</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Minimally invasive McKeown oesophagectomy is the mainstream surgical approach for oesophageal cancer treatment. Cervical anastomotic leakage (CAL) is a common postoperative complication, with an incidence ranging from 0% to 30% (<xref ref-type="bibr" rid="B1">1</xref>). CAL significantly affects patients&#x2019; quality of life, including prolonged hospital stay, frequent wound cleaning, unpleasant odour, psychological distress, and potentially life-threatening conditions (<xref ref-type="bibr" rid="B2">2</xref>). Although improvements in surgical techniques and perioperative management can reduce the incidence of CAL, this complication has not been entirely eliminated.</p>
<p>In recent years, negative-pressure wound therapy (NPWT) and NPWT with instillation (NPWTi) have emerged as effective methods for accelerating wound healing and are commonly used to treat pressure injuries, diabetic foot ulcers, and chronic osteomyelitis (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). However, reports on the use of NPWTi for CAL after oesophagectomy are sparse, and there is a risk of mediastinal and thoracic infections associated with its use. This paper presents an improved NPWTi method with broad clinical applicability aimed at reducing the risk of fistula infection, promoting wound healing, eliminating odour, reducing frequent dressing changes, and enhancing patients&#x2019; quality of life. This study aimed to provide effective clinical management strategies for these common and challenging complications.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Design and population</title>
<p>This study is a retrospective analysis of patients who underwent surgery for oesophageal cancer at our hospital between 2021 and 2024. All included patients subsequently developed a cervical anastomotic leak (CAL) and were treated with our modified NPWTi protocol. Patient data, including healing days, treatment frequency, comfort level, wound odour, and patient satisfaction, were collected.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Diagnosis of CAL</title>
<p>A diagnosis of CAL was based on one of the following:</p>
<sec id="s2_2_1">
<label>2.2.1</label>
<title>Clinical findings</title>
<p>Local swelling at the cervical incision, elevated skin temperature, and tenderness; upon incision opening, saliva or secretions were observed, accompanied by a foul odour.</p>
</sec>
<sec id="s2_2_2">
<label>2.2.2</label>
<title>Auxiliary examination findings</title>
<p>Gastrointestinal imaging revealed contrast agent overflow; gastroscopy confirmed the fistula.</p>
</sec>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Outcome measures</title>
<p>The primary and secondary outcomes in this study were as follows:</p>
<sec id="s2_3_1">
<label>2.3.1</label>
<title>Primary outcome</title>
<sec id="s2_3_1_1">
<label>2.3.1.1</label>
<title>Time to healing of CAL</title>
<p>This was defined as the number of days from the initial diagnosis of CAL to the commencement of modified NPWTi until the criteria for &#x201c;Healing of CAL&#x201d; were met (i.e., after the drainage device was removed, the cervical incision showed no salivary or secretory leakage or foul odour, and gastrointestinal imaging did not reveal any contrast overflow).</p>
</sec>
</sec>
<sec id="s2_3_2">
<label>2.3.2</label>
<title>Secondary outcomes</title>
<sec id="s2_3_2_1">
<label>2.3.2.1</label>
<title>Wound odour assessment</title>
<p>According to the World Union of Wound Healing Societies consensus document and the <italic>Grocott</italic> wound odour assessment criteria, wound odour is categorised into six levels (<xref ref-type="bibr" rid="B5">5</xref>):</p>
<list list-type="simple">
<list-item>
<p>- Level 0: Odour detectable upon entering the room.</p></list-item>
<list-item>
<p>- Level 1: Odour detectable within the patient&#x2019;s arm length.</p></list-item>
<list-item>
<p>- Level 2: Odour detectable at least one arm&#x2019;s length away.</p></list-item>
<list-item>
<p>- Level 3: Slight odour within arm&#x2019;s length.</p></list-item>
<list-item>
<p>- Level 4: Only the patient could smell it.</p></list-item>
<list-item>
<p>- Level 5: No odour.</p></list-item>
</list>
<p>Wound odour assessment was performed on the day of CAL diagnosis and 1&#xa0;d after modified NPWTi implementation.</p>
</sec>
<sec id="s2_3_2_2">
<label>2.3.2.2</label>
<title>Comfort evaluation</title>
<p>The pain assessment visual analogue scale (VAS) was used to evaluate comfort during treatment.</p>
</sec>
</sec>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Treatment of CAL</title>
<sec id="s2_4_1">
<label>2.4.1</label>
<title>Common treatment</title>
<p>All patients diagnosed with CAL received conventional treatments, including fasting, placement of enteral feeding tubes, enteral and parenteral nutritional support, and anti-infection measures. The cervical incision was fully opened, and dressings were changed intermittently to maintain cleanliness. Contaminants near the incision and anastomosis were thoroughly removed, along with necrotic oesophageal and gastric tissues.</p>
</sec>
<sec id="s2_4_2">
<label>2.4.2</label>
<title>Modified NPWTi</title>
<p>1. The stoma bag was trimmed to match the shape and size of the incision (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Custom-trimmed stoma bag applied to the incision site. The stoma bag was custom-trimmed to match the size and shape of the incision, ensuring a secure and airtight seal for the subsequent application of negative pressure.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1644593-g001.tif">
<alt-text content-type="machine-generated">Close-up of a medical stoma on a person's neck with adjacentsurgical stitches. A stoma bag covers part of the image, highlighting that the ostomy bag is specially made according to the shape of the neck incision.</alt-text>
</graphic></fig>
<p>2. A standard venous infusion catheter was inserted into the side hole of a 14F gastric tube (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2</bold></xref>), with the other end connected to an isotonic sodium chloride solution irrigation line at a drip rate of 20 to 30 drops per minute.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Assembly of the three-tube system. The system is composed of a standard venous infusion catheter and two 14F gastric tubes, which are colour-coded for easy identification. The brown rectangular dressings at the base of the figure are silver sulphate dressings.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1644593-g002.tif">
<alt-text content-type="machine-generated">Close-up of a gloved hand holding a clear medical tube, next to two bent tubes on a textured brown surface. The tubes are positioned parallel, with visible curvature.</alt-text>
</graphic></fig>
<p>3. The heads of the two 14F drainage tubes were wrapped and secured with a lipid hydrocolloid silver sulphate dressing to ensure smooth contact with the cervical wound (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Application of a silver sulphate dressing at the tube-wound interface. A silver sulphate dressing was applied to the exterior of the drainage tube, ensuring its smooth surface was in direct contact with the neck wound.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1644593-g003.tif">
<alt-text content-type="machine-generated">Two images are shown. The top image depicts a medical tube connected to a round adhesive pad. The bottom image shows gloved hands carefully handling a braided tube near a surgical incision on the neck area.</alt-text>
</graphic></fig>
<p>4. The drainage tubes were connected via a three-way device to a drainage bottle, which was linked to the central negative-pressure system. The pressure was maintained at approximately 0.05 MPa and adjusted based on the patient&#x2019;s subjective tolerance.</p>
<p>5. The adhesive dressing was trimmed to fit the patient&#x2019;s neck, ensuring a complete seal of the device (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4</bold></xref>). The continuous infusion and negative-pressure suction were then initiated (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5</bold></xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>The adhesive dressing is trimmed to create a secure perimeter. The adhesive dressing was trimmed into a serrated edge to conform to the contours of the stoma bag and skin, thus ensuring a complete and hermetic seal across the entire wound area.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1644593-g004.tif">
<alt-text content-type="machine-generated">A medical dressing with a transparent cover is applied to aperson's neck. A tube is inserted into the dressing, likely indicating a wound or drain site, with beige adhesive tape securing the edges.</alt-text>
</graphic></fig>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>The fully assembled system ready for activation. Following the assurance of a hermetic seal, the initiation of negative pressure suction and medicated infusion via the designated tubes may be undertaken.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1644593-g005.tif">
<alt-text content-type="machine-generated">A medical device attached to a person's neck area. Thedevice includes tubing and a clear protective covering secured with adhesive tape. The device is connected to a stoma or opening on the skin.</alt-text>
</graphic></fig>
</sec>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Statistical methods</title>
<p>Data were statistically analysed using IBM SPSS Statistics 26.0. Normally distributed continuous variables are presented as mean &#xb1; standard deviation; non-normally distributed variables as median and interquartile range; and categorical data as number (percentage). Wound odour scores, being ordinal data, were compared using the Wilcoxon signed-rank test. A <italic>P</italic> value of &lt;0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<p>A total of 17 patient were collected (<xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>), including 10 men and seven women, with an average age of 73.71 &#xb1; 8.01 years. None received neoadjuvant therapy, and no patients had diabetes; preoperative albumin was 38.77 &#xb1; 3.58 g/L. The occurrence of CAL was noted at 8.88 &#xb1; 3.15&#xa0;d (95% CI: 7.26 to 10.51&#xa0;d) post-surgery. The modified treatment was commenced 0&#x2013;12 d after CAL diagnosis, with the earliest case starting on the day of diagnosis. The mean duration of modified NPWTi was 10.88 &#xb1; 6.54&#xa0;d (95% CI: 7.52 to 14.25&#xa0;d). For the primary outcome, the time from treatment initiation to complete healing was 15.00 &#xb1; 7.26&#xa0;d (95% CI: 11.27 to 18.73&#xa0;d), with a minimum of five days. No mediastinal or pleural infections related to NPWTi occurred during the treatment. For the secondary outcomes, a significant improvement in wound odour was observed following the administration of the modified NPWTi (P&lt;0.001) (<xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref>), with an improvement rate of 100% (95% CI: 85-100%). During the treatment, the patients reported feeling comfortable and expressed overall satisfaction.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Characteristics.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Variable</th>
<th valign="middle" align="center">n=17</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Sex (male)</td>
<td valign="middle" align="center">10 (58.8%)</td>
</tr>
<tr>
<td valign="middle" align="left">Age (years)</td>
<td valign="middle" align="center">73.71 &#xb1; 8.01</td>
</tr>
<tr>
<td valign="middle" align="left">BMI (kg/m<sup>2</sup>)</td>
<td valign="middle" align="center">21.64 &#xb1; 2.55</td>
</tr>
<tr>
<td valign="middle" align="left">Diabetes</td>
<td valign="middle" align="center">0 (0%)</td>
</tr>
<tr>
<td valign="middle" align="left">ALB (g/L)</td>
<td valign="middle" align="center">38.77 &#xb1; 3.58</td>
</tr>
<tr>
<td valign="middle" align="left">Operation duration (min)</td>
<td valign="middle" align="center">345.59 &#xb1; 75.24</td>
</tr>
<tr>
<td valign="middle" align="left">Neoadjuvant treatment</td>
<td valign="middle" align="center">0 (0%)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Pathological subtype</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Highly differentiated ESCC</td>
<td valign="middle" align="center">0 (0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Moderately differentiated ESCC</td>
<td valign="middle" align="center">12 (70.5%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Poorly differentiated ESCC</td>
<td valign="middle" align="center">4 (23.5%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Sarcomatoid carcinoma</td>
<td valign="middle" align="center">1 (5.9%)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Pathological stage</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;T1</td>
<td valign="middle" align="center">1 (5.9%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;T2</td>
<td valign="middle" align="center">5 (29.4%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;T3</td>
<td valign="middle" align="center">11 (64.7%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;N0</td>
<td valign="middle" align="center">8 (47.1%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;N1</td>
<td valign="middle" align="center">5 (29.4)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;N2</td>
<td valign="middle" align="center">3 (17.6%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;N3</td>
<td valign="middle" align="center">1 (5.9%)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">VAS score during treatment</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;0</td>
<td valign="middle" align="center">2 (11.7%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;1</td>
<td valign="middle" align="center">5 (29.4%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;2</td>
<td valign="middle" align="center">5 (29.4%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;3</td>
<td valign="middle" align="center">5 (29.4%)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Feeding type</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Jejunostomy tube</td>
<td valign="middle" align="center">4 (23.5%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Nasoduodenal feeding tube</td>
<td valign="middle" align="center">13 (76.5%)</td>
</tr>
<tr>
<td valign="middle" align="left">Postoperative time to CAL diagnosis (d)</td>
<td valign="middle" align="center">8.88 &#xb1; 3.15</td>
</tr>
<tr>
<td valign="middle" align="left">Duration of improved NPWTi (d)</td>
<td valign="middle" align="center">10.88 &#xb1; 6.54</td>
</tr>
<tr>
<td valign="middle" align="left">Healing time for CAL (d)</td>
<td valign="middle" align="center">15.00 &#xb1; 7.26</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>ALB, albumin; BMI, body mass index; CAL, cervical anastomotic leakage; NPWTi, negative pressure wound therapy with instillation; ESCC, oesophageal squamous cell carcinoma; VAS, visual analogue scale.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Grocott odour assessment before and after modified NPWTi.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Grocott odour assessment<sup>a</sup></th>
<th valign="middle" align="center">Before modified NPWTi (n=17)</th>
<th valign="middle" align="center">After modified NPWTi (n=17)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">level 0</td>
<td valign="middle" align="center">13 (76.5%)</td>
<td valign="middle" align="center">0 (0%)</td>
</tr>
<tr>
<td valign="middle" align="center">level 1</td>
<td valign="middle" align="center">4 (23.5%)</td>
<td valign="middle" align="center">0 (0%)</td>
</tr>
<tr>
<td valign="middle" align="center">level 2</td>
<td valign="middle" align="center">0 (0%)</td>
<td valign="middle" align="center">0 (0%)</td>
</tr>
<tr>
<td valign="middle" align="center">level 3</td>
<td valign="middle" align="center">0 (0%)</td>
<td valign="middle" align="center">4 (23.5%)</td>
</tr>
<tr>
<td valign="middle" align="center">level 4</td>
<td valign="middle" align="center">0 (0%)</td>
<td valign="middle" align="center">6 (35.3%)</td>
</tr>
<tr>
<td valign="middle" align="center">level 5</td>
<td valign="middle" align="center">0 (0%)</td>
<td valign="middle" align="center">7 (41.2%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="fnT2_1"><label>a</label>
<p>Variable <italic>P</italic> value was calculated by Wilcoxon signed-rank test, <italic>P</italic> &lt;0.001.</p></fn>
<fn>
<p>NPWTi, negative pressure wound therapy with instillation.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<sec id="s4_1">
<label>4.1</label>
<title>CAL after oesophageal cancer operation</title>
<p>Tension, local blood supply, and surgical duration are recognised risk factors for CAL after oesophageal cancer surgery. Additional perioperative factors include neoadjuvant therapy (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B6">6</xref>), diabetes, body weight (<xref ref-type="bibr" rid="B7">7</xref>), and preoperative hypoproteinaemia. Conventional treatment for CAL involves complete opening of the cervical incision, adequate drainage, and daily wound cleaning until healing. Patients typically require fasting, enteral feeding tube placement, nutritional support, and antibiotics. This treatment process not only has a long duration but also increases hospital stay and costs, while frequent dressing changes add to the workload of healthcare staff and create psychological stress for patients.</p>
</sec>
<sec id="s4_2">
<label>4.2</label>
<title>NPWT and NPWTi</title>
<p>NPWT is a recent therapeutic approach that promotes wound healing. Continuous negative pressure removes wound exudates and sources of infection, prevents the spread of infection, and protects the wound. NPWT promotes neovascularization and the expression of related growth factors (<xref ref-type="bibr" rid="B8">8</xref>&#x2013;<xref ref-type="bibr" rid="B10">10</xref>). It is widely used to treat pressure ulcers, leg ulcers, poor postoperative healing, diabetic foot ulcers, and various wounds.</p>
<p>Compared to NPWT, NPWTi enhances wound hydration through a stable irrigation fluid, accelerates wound cleaning, and aids in the dissolution and removal of deep necrotic tissue, thereby reducing the absolute bioburden (<xref ref-type="bibr" rid="B11">11</xref>) and improving bacterial clearance. NPWTi significantly reduces healing time for infected wounds compared with that of traditional moist wound healing (29.6 &#xb1; 6.5 vs. 13.2 &#xb1; 6.8&#xa0;d, <italic>P</italic>&#xa0;&lt;&#xa0;0.001) (<xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>However, healing in CAL cases is fundamentally characterised by the growth of granulation tissue, forming a sinus with prolonged exposure to digestive fluids and saliva, leading to slow healing (<xref ref-type="bibr" rid="B13">13</xref>). A meta-analysis of 11 studies indicated that the average duration of CAL treatment was 34 days (<xref ref-type="bibr" rid="B14">14</xref>). In this context, the primary outcome of our study demonstrates that the use of our modified NPWTi was associated with a substantially reduced time to healing of 15.00 &#xb1; 7.26 days. This finding is particularly notable when considering the expected healing timeline with standard care. While previous studies have confirmed that NPWT is effective and well-tolerated in CAL treatment (<xref ref-type="bibr" rid="B15">15</xref>), the risk of infection dissemination with standard NPWTi remains a concern, which our modifications aimed to mitigate.</p>
</sec>
<sec id="s4_3">
<label>4.3</label>
<title>Technical refinements to NPWTi for enhanced safety</title>
<p>During surgery, the anatomical positioning of the oesophagus allows the cervical incision to connect with the mediastinum and thoracic cavity. Continuous infusion and irrigation are required to maintain an effective negative pressure and avoid dispersion of the irrigation fluid. However, excessive suction may hinder the effectiveness of NPWTi, necessitating a balance between the infusion and suction. We propose the following modifications:</p>
<sec id="s4_3_1">
<label>4.3.1</label>
<title>Three-tube system</title>
<p>A small tube is used to control the infusion speed and is embedded within a larger tube to prevent excessive fluid soaking of the wound. Additionally, dual-channel negative pressure drainage can adequately drain large amounts of exudate and inflammatory necrotic material, thereby preventing the further spread of infection.</p>
</sec>
<sec id="s4_3_2">
<label>4.3.2</label>
<title>Preventing blockage</title>
<p>We believe that the blockage of the suction channel is a significant cause of the spread of infection in NPWTi applications for CAL. Dual-channel suction can prevent system failure in the event of single-channel blockage. We also used a lipid hydrocolloid silver sulphate dressing around the suction catheter tip (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref>), which filters out larger necrotic debris and utilises silver ions for antibacterial effects, thereby reducing the bacterial bioburden (<xref ref-type="bibr" rid="B16">16</xref>&#x2013;<xref ref-type="bibr" rid="B18">18</xref>). Smooth dressings also protect the wound by minimising direct damage from negative-pressure suction.</p>
<p>With our modified NPWTi process, we did not observe any cases of CAL progressing to a mediastinal or pleural infection.</p>
</sec>
</sec>
<sec id="s4_4">
<label>4.4</label>
<title>Odor management and patient comfort</title>
<p>As secondary outcomes, wound odour management and patient comfort were areas of significant focus. We utilised Grocott&#x2019;s wound odour assessment criteria to evaluate patients before and after receiving the modified NPWTi, revealing notable improvements. NPWTi effectively seals the cervical incision, isolating it from the odours of digestive fluids and saliva, a result that was well received by most patients and their families. Furthermore, patients reported comfort during the treatment, with a maximum pain VAS score of 3, and expressed overall satisfaction with the procedure.</p>
</sec>
<sec id="s4_5">
<label>4.5</label>
<title>Reduce the substantial workload</title>
<p>In our study of 17 patients, 14 required only one session of modified NPWTi, whereas three required two sessions, primarily because of incomplete removal of necrotic oesophageal and gastric tissue post-CAL diagnosis. After initiating NPWTi, the nursing staff regularly cleaned the drainage bottles and monitored changes in the exudate without requiring additional treatment for the cervical incision, significantly reducing the workload.</p>
</sec>
<sec id="s4_6">
<label>4.6</label>
<title>Limitations and clinical implications</title>
<p>This study has several limitations that should be considered. Firstly, it is a single-centre exploratory investigation with a small sample size and the absence of a concurrent control group, which limits the generalisability and statistical power of its findings. Future validation through prospective, large-scale, multicentre studies is therefore necessary. Secondly, our method&#x2019;s reliance on the hospital&#x2019;s central negative pressure system restricts patient mobility. There is a practical trade-off between the wide availability and lower cost of central systems and the mobility and potentially more precise control offered by portable negative pressure devices, which come at a higher cost. This consideration directly impacts resource use and implementation strategy in different clinical settings (<xref ref-type="bibr" rid="B15">15</xref>). Furthermore, while the assessment of secondary outcomes like odour improvement was performed using established criteria, the perception of odour remains somewhat subjective. Future research should aim to develop and apply more objective, quantitative assessment tools to minimise potential bias.</p>
<p>Despite these limitations, the modified NPWTi demonstrates promise as a feasible and safe intervention for managing CAL. It is associated with a potentially shorter healing time compared to literature-derived benchmarks for standard care, alongside observed benefits in symptom control and nursing efficiency. These encouraging findings warrant further investigation through robust comparative studies, which are needed to validate the efficacy and cost-effectiveness of this modified approach and to guide its broader clinical implementation.</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusion">
<label>5</label>
<title>Conclusion</title>
<p>The application of modified NPWTi in CAL after oesophageal cancer surgery is effective, simple, safe, and beneficial to both healthcare staff and patients. These outcomes warrant further investigation and indicate its potential for widespread clinical implementation.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Ethics Committee of Gaozhou People&#x2019;s Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p></sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>LZ: Writing &#x2013; review &amp; editing, Funding acquisition, Resources, Conceptualization. JH: Writing &#x2013; original draft. XG: Writing &#x2013; original draft, Project administration, Formal analysis. JX: Writing &#x2013; original draft, Validation, Methodology, Data curation. WL: Project administration, Writing &#x2013; review &amp; editing, Formal analysis. BW: Project administration, Data curation, Validation, Writing &#x2013; review &amp; editing. YC: Writing &#x2013; review &amp; editing, Project administration, Visualization, Resources. CL: Methodology, Investigation, Writing &#x2013; original draft. LG: Formal analysis, Funding acquisition, Writing &#x2013; review &amp; editing, Resources.</p></sec>
<ack>
<title>Acknowledgments</title>
<p>The authors would like to thank Huilong Chen, the principal investigator of the Guangdong Medical Research Fund Project (B2023212), for his support and guidance throughout this research.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kamarajah</surname> <given-names>SK</given-names></name>
<name><surname>Lin</surname> <given-names>A</given-names></name>
<name><surname>Tharmaraja</surname> <given-names>T</given-names></name>
<name><surname>Bharwada</surname> <given-names>Y</given-names></name>
<name><surname>Bundred</surname> <given-names>JR</given-names></name>
<name><surname>Nepogodiev</surname> <given-names>D</given-names></name>
<etal/>
</person-group>. 
<article-title>Risk factors and outcomes associated with anastomotic leaks following esophagectomy: a systematic review and meta-analysis</article-title>. <source>Dis Esophagus</source>. (<year>2020</year>) <volume>33</volume>:<elocation-id>doz089</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/dote/doz089</pub-id>, PMID: <pub-id pub-id-type="pmid">31957798</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Biere</surname> <given-names>SS</given-names></name>
<name><surname>Maas</surname> <given-names>KW</given-names></name>
<name><surname>Cuesta</surname> <given-names>MA</given-names></name>
<name><surname>van der Peet</surname> <given-names>DL</given-names></name>
</person-group>. 
<article-title>Cervical or thoracic anastomosis after esophagectomy for cancer: a systematic review and meta-analysis</article-title>. <source>Dig Surg</source>. (<year>2011</year>) <volume>28</volume>:<fpage>29</fpage>&#x2013;<lpage>35</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000322014</pub-id>, PMID: <pub-id pub-id-type="pmid">21293129</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Raphael</surname> <given-names>A</given-names></name>
<name><surname>Gonzales</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>Use of cryopreserved umbilical cord with negative pressure wound therapy for complex diabetic ulcers with osteomyelitis</article-title>. <source>J Wound Care</source>. (<year>2017</year>) <volume>26</volume>:<page-range>S38&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.12968/jowc.2017.26.Sup10.S38</pub-id>, PMID: <pub-id pub-id-type="pmid">28976835</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cuomo</surname> <given-names>R</given-names></name>
<name><surname>Nisi</surname> <given-names>G</given-names></name>
<name><surname>Grimaldi</surname> <given-names>L</given-names></name>
<name><surname>Brandi</surname> <given-names>C</given-names></name>
<name><surname>D&#x2019;Aniello</surname> <given-names>C</given-names></name>
</person-group>. 
<article-title>Use of ultraportable vacuum therapy systems in the treatment of venous leg ulcer</article-title>. <source>Acta BioMed</source>. (<year>2017</year>) <volume>88</volume>:<fpage>297</fpage>&#x2013;<lpage>301</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.23750/abm.v88i3.5737</pub-id>, PMID: <pub-id pub-id-type="pmid">29083334</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Grocott</surname> <given-names>P</given-names></name>
</person-group>. 
<article-title>Developing a tool for researching fungating wounds</article-title>. <source>World wide wounds</source>. (<year>2001</year>).
</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gao</surname> <given-names>W</given-names></name>
<name><surname>Wang</surname> <given-names>M</given-names></name>
<name><surname>Su</surname> <given-names>P</given-names></name>
<name><surname>Zhang</surname> <given-names>F</given-names></name>
<name><surname>Huang</surname> <given-names>C</given-names></name>
<name><surname>Tian</surname> <given-names>Z</given-names></name>
</person-group>. 
<article-title>Risk factors of cervical anastomotic leakage after mcKeown minimally invasive esophagectomy: focus on preoperative and intraoperative lung function</article-title>. <source>Ann Thorac Cardiovasc Surg</source>. (<year>2021</year>) <volume>27</volume>:<fpage>75</fpage>&#x2013;<lpage>83</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.5761/atcs.oa.20-00139</pub-id>, PMID: <pub-id pub-id-type="pmid">33087661</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ri</surname> <given-names>M</given-names></name>
<name><surname>Miyata</surname> <given-names>H</given-names></name>
<name><surname>Aikou</surname> <given-names>S</given-names></name>
<name><surname>Seto</surname> <given-names>Y</given-names></name>
<name><surname>Akazawa</surname> <given-names>K</given-names></name>
<name><surname>Takeuchi</surname> <given-names>M</given-names></name>
<etal/>
</person-group>. 
<article-title>Effects of body mass index (BMI) on surgical outcomes: a nationwide survey using a Japanese web-based database</article-title>. <source>Surg Today</source>. (<year>2015</year>) <volume>45</volume>:<page-range>1271&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00595-015-1231-2</pub-id>, PMID: <pub-id pub-id-type="pmid">26263911</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fleischmann</surname> <given-names>W</given-names></name>
<name><surname>Strecker</surname> <given-names>W</given-names></name>
<name><surname>Bombelli</surname> <given-names>M</given-names></name>
<name><surname>Kinzl</surname> <given-names>L</given-names></name>
</person-group>. 
<article-title>Vacuum sealing as treatment of soft tissue damage in open fractures</article-title>. <source>Unfallchirurg</source>. (<year>1993</year>) <volume>96</volume>:<page-range>488&#x2013;92</page-range>.
</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Langer</surname> <given-names>V</given-names></name>
<name><surname>Bhandari</surname> <given-names>PS</given-names></name>
<name><surname>Rajagopalan</surname> <given-names>S</given-names></name>
<name><surname>Mukherjee</surname> <given-names>MK</given-names></name>
</person-group>. 
<article-title>Negative pressure wound therapy as an adjunct in healing of chronic wounds</article-title>. <source>Int Wound J</source>. (<year>2015</year>) <volume>12</volume>:<page-range>436&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/iwj.12132</pub-id>, PMID: <pub-id pub-id-type="pmid">23855645</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname> <given-names>Y</given-names></name>
<name><surname>Tang</surname> <given-names>N</given-names></name>
<name><surname>Cao</surname> <given-names>K</given-names></name>
<name><surname>Wang</surname> <given-names>S</given-names></name>
<name><surname>Tang</surname> <given-names>S</given-names></name>
<name><surname>Su</surname> <given-names>H</given-names></name>
<etal/>
</person-group>. 
<article-title>Negative-Pressure Wound Therapy Promotes Wound Healing by Enhancing Angiogenesis Through Suppression of NLRX1 via miR-195 Upregulation</article-title>. <source>Int J Low Extrem Wounds</source>. (<year>2018</year>) <volume>17</volume>:<page-range>144&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/1534734618794856</pub-id>, PMID: <pub-id pub-id-type="pmid">30141361</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Goss</surname> <given-names>SG</given-names></name>
<name><surname>Schwartz</surname> <given-names>JA</given-names></name>
<name><surname>Facchin</surname> <given-names>F</given-names></name>
<name><surname>Avdagic</surname> <given-names>E</given-names></name>
<name><surname>Gendics</surname> <given-names>C</given-names></name>
<name><surname>Lantis</surname> <given-names>JC</given-names> <suffix>2nd</suffix></name>
</person-group>. 
<article-title>Negative pressure wound therapy with instillation (NPWTi) better reduces post-debridement bioburden in chronically infected lower extremity wounds than NPWT alone</article-title>. <source>J Am Coll Clin Wound Spec</source>. (<year>2012</year>) <volume>4</volume>:<fpage>74</fpage>&#x2013;<lpage>80</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jccw.2014.02.001</pub-id>, PMID: <pub-id pub-id-type="pmid">26199877</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gabriel</surname> <given-names>A</given-names></name>
<name><surname>Shores</surname> <given-names>J</given-names></name>
<name><surname>Heinrich</surname> <given-names>C</given-names></name>
<name><surname>Baqai</surname> <given-names>W</given-names></name>
<name><surname>Kalina</surname> <given-names>S</given-names></name>
<name><surname>Sogioka</surname> <given-names>N</given-names></name>
<etal/>
</person-group>. 
<article-title>Negative pressure wound therapy with instillation: a pilot study describing a new method for treating infected wounds</article-title>. <source>Int Wound J</source>. (<year>2008</year>) <volume>5</volume>:<fpage>399</fpage>&#x2013;<lpage>413</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1742-481X.2007.00423.x</pub-id>, PMID: <pub-id pub-id-type="pmid">18593390</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ma</surname> <given-names>H</given-names></name>
<name><surname>Song</surname> <given-names>X</given-names></name>
<name><surname>Li</surname> <given-names>J</given-names></name>
<name><surname>Zhao</surname> <given-names>G</given-names></name>
</person-group>. 
<article-title>Application of mediastinal drainage tube in intrathoracic esophageal anastomotic leakage for early diagnosis and effective treatment: a retrospective study</article-title>. <source>J Cardiothorac Surg</source>. (<year>2021</year>) <volume>16</volume>:<fpage>52</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13019-021-01435-9</pub-id>, PMID: <pub-id pub-id-type="pmid">33766053</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Verstegen</surname> <given-names>M</given-names></name>
<name><surname>Bouwense</surname> <given-names>S</given-names></name>
<name><surname>van Workum</surname> <given-names>F</given-names></name>
<name><surname>Ten Broek</surname> <given-names>R</given-names></name>
<name><surname>Siersema</surname> <given-names>PD</given-names></name>
<name><surname>Rovers</surname> <given-names>M</given-names></name>
<etal/>
</person-group>. 
<article-title>Management of intrathoracic and cervical anastomotic leakage after esophagectomy for esophageal cancer: a systematic review</article-title>. <source>World J Emerg Surg</source>. (<year>2019</year>) <volume>14</volume>:<fpage>17</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13017-019-0235-4</pub-id>, PMID: <pub-id pub-id-type="pmid">30988695</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Luo</surname> <given-names>BJ</given-names></name>
<name><surname>Zhang</surname> <given-names>HQ</given-names></name>
<name><surname>Zhong</surname> <given-names>JD</given-names></name>
<name><surname>He</surname> <given-names>XZ</given-names></name>
<name><surname>Shen</surname> <given-names>F</given-names></name>
<name><surname>Zheng</surname> <given-names>MC</given-names></name>
<etal/>
</person-group>. 
<article-title>A randomized trial of negative pressure wound therapy technology combined with intermittent instillation in the treatment of neck anastomotic leakage after esophageal cancer surgery</article-title>. <source>J Gastrointest Oncol</source>. (<year>2021</year>) <volume>12</volume>:<page-range>2665&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.21037/jgo-21-605</pub-id>, PMID: <pub-id pub-id-type="pmid">35070396</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Raghupathy</surname></name>
<name><surname>Sabrena</surname></name>
<name><surname>Vaithiswaran</surname> <given-names>A</given-names></name>
<name><surname>Franklin</surname> <given-names>A</given-names></name>
<name><surname>Kailasam</surname> <given-names>S</given-names></name>
</person-group>. 
<article-title>A prospective randomized trial of vacuum-assisted closure versus standard therapy of chronic non-healing wounds</article-title>. <source>J Evolution Med Dent Sci</source>. (<year>2016</year>) <volume>5</volume>:<page-range>3162&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.14260/jemds/2016/733</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gupta</surname> <given-names>S</given-names></name>
<name><surname>Cho</surname> <given-names>T</given-names></name>
</person-group>. 
<article-title>A literature review of negative pressure wound therapy</article-title>. <source>Wounds-A Compendium Clin Res Pract</source>. (<year>2004</year>), <fpage>6s</fpage>&#x2013;<lpage>8s</lpage>.
</mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Namviriyachote</surname> <given-names>N</given-names></name>
<name><surname>Lipipun</surname> <given-names>V</given-names></name>
<name><surname>Akkhawattanangkul</surname> <given-names>Y</given-names></name>
<name><surname>Charoonrut</surname> <given-names>P</given-names></name>
<name><surname>Ritthidej</surname> <given-names>GC</given-names></name>
</person-group>. 
<article-title>Development of polyurethane foam dressing containing silver and asiaticoside for healing of dermal wound</article-title>. <source>Asian J Pharm Sci</source>. (<year>2019</year>) <volume>14</volume>:<fpage>63</fpage>&#x2013;<lpage>77</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ajps.2018.09.001</pub-id>, PMID: <pub-id pub-id-type="pmid">32104439</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1163034">Savvas Lampridis</ext-link>, Imperial College London, United Kingdom</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1823098">Christian Bohringer</ext-link>, UC Davis Medical Center, United States</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1197712">Gang Lin</ext-link>, Peking University, China</p></fn>
</fn-group>
</back>
</article>